4//SEC Filing
Steinfels George F 4
Accession 0000893838-05-000122
CIK 0001228627other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:27 PM ET
Size
8.9 KB
Accession
0000893838-05-000122
Insider Transaction Report
Form 4
Steinfels George F
Chief Business Officer Sr. VP
Transactions
- Award
Stock Option (right to buy)
2005-05-13+250,000→ 250,000 totalExercise: $0.24Exp: 2014-09-15→ Common Stock (250,000 underlying) - Award
Stock Option: (right to buy)
2005-05-13+500,000→ 500,000 totalExercise: $0.24Exp: 2015-01-20→ Common Stock (500,000 underlying)
Footnotes (3)
- [F1]The options vest and become exercisable as to 30% of the options on September 15, 2005; another 30% of the options on September 15, 2006; and the remaining 40% of the options on September 15, 2007.
- [F2]The options vest and become exercisable as to 30% of the options on January 20, 2006; another 30% of the options on January 20, 2007; and the remaining 40% of the options on January 20, 2008.
- [F3]These options were acquired pursuant to the Agreement and Plan of Merger (the "Merger Agreement") among the Issuer, Rexahn, Corp and the wholly-owned subsidiaries of the Issuer, whereby each outstanding option of Rexahn, Corp was converted into five options to purchase shares of Issuer common stock. Such new option is otherwise subject to the same terms of the original option, except that the exercise price per share of Issuer common stock under the Issuer option is equal to the exercise price per share of Rexahn, Corp common stock under the original option, divided by five (rounded up to the nearest hundredth of a cent; provided, however, that in no event is the exercise price per share of any Issuer common stock less than $.0001).
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001317412
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 9:27 PM ET
- Size
- 8.9 KB